No matches

4 search results for: heterogeneity

Chronic Obstructive Pulmonary Disease: Disease Burden & <b>Heterogeneity</b>
Pulmonology
Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
interactivity

Learn about the disease burden and heterogeneity of chronic obstructive pulmonary disease (COPD).

View more
<b>Heterogeneity</b> and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU
Dermatology
Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU
expert video

In this video from EADV 2025, Dr. Netchiporouk discusses the clinical features, diagnosis, and burden of CSU

View more
Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes
Pulmonology
Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes
interactivity

This infographic outlines how endotyping, phenotyping, and genotyping are interrelated concepts that are crucial for improving the way patients with COPD are characterized and how understanding these concepts can better optimize patient care

View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: EstoniaChange country/region